Source link : https://newshealth.biz/health-news/new-aml-regimen-for-unfit-patients-gets-fdas-blessing/
The FDA on Wednesday approved a new all-oral regimen for newly diagnosed acute myeloid leukemia (AML) in patients ineligible for intensive chemotherapy. The combination of decitabine-cedazuridine (Inqovi) plus venetoclax (Venclexta) is specifically indicated for either adults 75 and older or those whose comorbidities would preclude an intensive induction regimen — a group that comprises over […]
The post New AML Regimen for Unfit Patients Gets FDA’s Blessing first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-14 21:34:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8